Sermorelin, 5mg

Product Category

Growth Hormone Releasing Hormone (GHRH) Analogs & Secretagogues

Action on the Human Body

Sermorelin is a synthetic 29-amino acid peptide representing the fully functional N-terminal fragment of endogenous Growth Hormone Releasing Hormone (GHRH 1-29). It acts as a direct agonist at GHRH receptors on pituitary somatotropes, triggering a cascade that mimics native hypothalamic pulsatile signaling. This stimulates the production and secretional wave of Growth Hormone (GH), down-streaming to raise systemic Insulin-like Growth Factor-1 (IGF-1) concentrations. Sermorelin respects negative feedback loops, preventing the sudden receptor depletion and endocrine suppression associated with raw growth hormone introduction while upregulating fat loss via lipolysis and improving nitrogen balance within skeletal muscle.

What to Expect if Consumed

Users experience a substantial correction in deep sleep cycles, gradual reduction in belly fat layers, faster physical recovery under stress, and improved connective tissue resilience.

Possible Therapy Combinations

Pairs perfectly with selective options like Ipamorelin to trigger a highly synergistic, dual-signal growth hormone peak without disturbing cortisol thresholds.

Molecular Formula & Chemical Composition

Sequence: 29-amino acid primary structure peptide. Molecular Formula: C149H246N44O42S. Purity: >99% Pure HPLC Certified Lyophilized Matrix.

WARNING: This peptide compound must be handled and utilized exclusively under very high, correct professional and qualified medical supervision. Misuse can lead to unintended biological variations.

Scientific References

1. Walker, R. F., et al. (1990). ‘Effects of sermorelin (GHRH 1-29) on growth hormone output profiles in young and aging models.’ Journal of Endocrinology.
2. Prakash, A., et al. (1999). ‘Sermorelin: A clinical review of its use in age-related growth hormone decline states.’ Drugs & Aging.